Skip to content

Proof-of-Concept of an Integrated Yoga and Psychological Intervention in Mitigating Distress Among Diverse Women With Gynecologic, Gastrointestinal, and Thoracic Cancers.

Grace Ann Hanvey, Elizabeth L Kacel, Kelsey C Bacharz, Adaixa Padrón Wilborn, Sonia Mesa, Halle McCracken, Irene M. Estores, Merry-Jennifer Markham, Frederic J Kaye, Dennie Jones, Thomas J George, Deidre B Pereira

Integrative Cancer Therapies 2024 DOI: 10.1177/15347354241283113 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Proof-of-concept single-arm study Randomized Peer reviewed
Sample size 125
Population Women with gynecologic, gastrointestinal, and thoracic cancers, including women of color and lower socioeconomic status
Intervention psychotherapy skills
Duration 10-week intervention; outcomes measured at baseline and following intervention
Topics Anxiety Depression Meditation
Keywords Humans Gastrointestinal neoplasms Thoracic neoplasms Genital neoplasms, female Neoplasm recurrence, local Stress, psychological Adult Middle aged Psychological distress Psychosocial intervention Psychological intervention Health disparities Psycho-oncology Cancer distress Yoga intervention
Registration NCT03385577
Key points An integrated group yoga and psychological intervention was associated with reductions in total and somatic depressive symptoms and state anxiety. Higher socioeconomic status was associated with greater reductions in fear-of-recurrence distress and depressive symptoms, and women of color showed greater declines in somatic symptoms than non-Hispanic White women. The authors present these as proof-of-concept findings and call for a randomized controlled trial.

Abstract

Background: Fear of cancer recurrence (FCR), cancer-distress, depression, and anxiety are prevalent concerns among women with gynecologic and other understudied cancers, especially among women of color and lower socioeconomic status (SES). Evidence indicates that mind-body interventions are effective in reducing such distress. This study evaluates (1) proof-of-concept of an integrated group yoga and psychological intervention in alleviating distress among women with gynecologic, gastrointestinal, and thoracic cancers and (2) differences in efficacy across social and economic factors.

Methods: One hundred twenty-five participants were enrolled in a 10-week, single-arm, integrated group intervention utilizing mindfulness meditation, psychotherapy skills, and yoga. They completed measures of FCR, cancer-distress, depression, and anxiety at baseline and following intervention. Mixed-linear models evaluated change in outcomes across the intervention and moderating effects of age, minority status, and SES among 51 participants with available data.

Results: Reductions in total (b = -2.06, P = .012) and somatic depressive symptoms (b = -1.79, P = .002) and state anxiety (b = -6.21, P = .005) were observed across the sample. Higher SES was associated with greater reductions in psychosocial distress related to FCR (b = -0.74, P = .050), and in total (b = -1.06, P = .049) and affective depressive symptoms (b = -0.76, P = .006). Women of color experienced greater declines in somatic symptoms compared to non-Hispanic White women (b = -2.71, P = .031), with women of color experiencing lower SES exhibiting greatest reduction in these symptoms (b = 1.73, P = .026).

Conclusions: This study demonstrates proof-of-concept that an integrated psychological and yoga intervention may reduce depressive symptoms and state anxiety among women with gynecologic, gastrointestinal, and thoracic cancers, with racial and/or ethnic minority status and SES moderating some of these effects. Future research should examine intervention feasibility and acceptability among diverse women with cancer and evaluate efficacy using a randomized controlled trial design.Trial

Registration: ClinicalTrials.gov NCT03385577.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Explore topics